C57BL/6-Cd3etm2(CD3E)Bcgen Erbb2tm1(ERBB2)Bcgen/Bcgen • 121249
| Product name | B-hCD3E/hHER2 mice |
|---|---|
| Catalog number | 121249 |
| Strain name | C57BL/6-Cd3etm2(CD3E)Bcgen Erbb2tm1(ERBB2)Bcgen/Bcgen |
| Strain background | C57BL/6 |
| NCBI gene ID | 2064,916 (Human) |
| Aliases | NEU; NGL; HER2; TKR1; CD340; HER-2; VSCN2; MLN 19; MLN-19; c-ERB2; c-ERB-2; HER-2/neu; p185(erbB2); T3E; TCRE; IMD18; CD3epsilon |
Immunohistochemical (IHC) analysis of HER2 expression in homozygous B-hCD3E/hHER2 mice. The mammary gland tissues were collected from WT and homozygous B-hHER2 mice (H/H; H/H) and analyzed by IHC with anti-Her2 antibody. HER2 was detectable in WT mice and homozygous B-hHER2 mice due to the cross-reactivity of the antibody. The arrow indicates tissue cells with positive HER2 staining (brown).
Antitumor activity of anti-human CD3/HER2 BsAbs (provided by a client) in B-hCD3E/HER2 mice. (A) Anti-human CD3/HER2 antibody BsAbs inhibited B-hHER2 MC38 plus tumor growth in B-hCD3E/HER2 mice. Murine colon cancer B-hHER2 MC38 plus cells were subcutaneously implanted into homozygous B-hCD3E/HER2 mice (female, 7-9-week-old, n=6). Mice were grouped when tumor volume reached approximately 100 mm3, at which time they were intraperitoneally injected with anti-human CD3/HER2 BsAbs Ab1 (provided by a client) indicated in panel. (B) Body weight changes during treatment. As shown in panel A, anti-human CD3/HER2 BsAbs Ab1 (provided by a client) was efficacious in controlling tumor growth in B-hCD3E/HER2 mice, demonstrating that the B-hCD3E/HER2 mice provide a powerful preclinical model for in vivo evaluation of anti-human CD3/HER2 BsAbs. Values are expressed as mean ± SEM.